Cleared Traditional

K822574 - INNOMED PD-1 KIT

K822574 is an FDA 510(k) clearance for INNOMED PD-1 KIT, manufactured by Innomed Corp.. The device is a Class 1 General Hospital device with product code LJL cleared through the Traditional 510(k) pathway after a 50-day FDA review.

K822574 · Innomed Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1982
Decision
50d
Days
Class 1
Risk

K822574 is an FDA 510(k) clearance for the INNOMED PD-1 KIT. Classified as Detectors And Removers, Lice, (including Combs) (product code LJL), Class I - General Controls.

Submitted by Innomed Corp. (Valrico, US). The FDA issued a Cleared decision on October 13, 1982 after a review of 50 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5960 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Innomed Corp. devices

FDA 510(k) Submission Details - K822574

510(k) Number K822574 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 1982
Decision Date October 13, 1982
Days to Decision 50 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
79d faster than avg
Panel avg: 129d · This submission: 50d
Pathway characteristics
Predicate-based equivalence.

LJL Device Classification - Class 1, General Controls

Product Code LJL Detectors And Removers, Lice, (including Combs)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 880.5960
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.